In our weekly check, Smith & Nephew plc is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 4, red flags: 0.
Smith & Nephew plc is a Healthcare company (Medical - Devices) based in the United Kingdom, listed on LSE as SN.L.
PEN · ALGN · GMED · GKOS · PODD · BIO
In our weekly check, Smith & Nephew plc is graded B (A to F). Of 25 checks on debt, profit, cash flow and trend: 21 pass, warnings: 4, red flags: 0. The grade is a risk check, not a buy or sell recommendation.
This week's biggest flags for Smith & Nephew plc: Gross margin falling, Weak revenue forecast, Deep past fall. In total 4 of 25 checks show a warning or a red flag.
Smith & Nephew plc is a Healthcare company (Medical - Devices) based in the United Kingdom, listed on LSE as SN.L.
The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.
Updated 2026-10-24